ARCHIVES

Drugs and Targets: FDA extends Lymphoseek label to include mapping in solid tumors

This article is from The Cancer Letter archive.

Vol. 40 No. 41 | October 31, 2014

Download PDF Visit The Full Archive

Related Articles

ASCO Names Stratetic Planning Committee

September 23, 1988

Major Changes Being Considered By NCI For FCRA

April 14, 1978

In NEJM Letter, Henschke Acknowledges Error In 2006 I-ELCAP Paper; Critics Call For Audit.

August 8, 2008

FDA Approves Gleevec For First Line Rx Of CML

January 31, 2003

Obama Lifts Ban on Federal Funding for Embryonic Stem Cell Research, Signs Memo on Scientific Integrity

March 13, 2009

One Year Later, Cancer Centers And NCI are Getting Along Just Fine, AACI Learns

July 27, 1990